Tumor Necrosis Factor Antagonist Responsiveness in a United States Rheumatoid Arthritis Cohort-Reference-Cited by-同舟云学术

Tumor Necrosis Factor Antagonist Responsiveness in a United States Rheumatoid Arthritis Cohort

Published:2008-06 Issue:6 Volume:121 Page:532-538
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Greenberg Jeffrey D.,Kishimoto Mitsumasa,Strand Vibeke,Cohen Stanley B.,Olenginski Thomas P.,Harrington Thomas,Kafka Shelly P.,Reed George,Kremer Joel M.

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial;Maini;Lancet,1999

2. Etanercept therapy in rheumatoid arthritis;Moreland;Ann Intern Med,1999

3. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial;Weinblatt;Arthritis Rheum,2003

4. The benefit/risk profile of TNF-blocking agents: findings of a consensus panel;Hochberg;Semin Arthritis Rheum,2005

5. Results from controlled clinical trials: how relevant for clinical practice?;Kvien;J Rheumatol,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study;Metabolomics;2021-08-16

2. Methotrexate and Cardiovascular Disease in Patients With Rheumatoid Arthritis: Insights and Novel Speculations;The Journal of Rheumatology;2021-03-15

3. Tools and Methods for Real-World Evidence Generation;Rheumatic Disease Clinics of North America;2019-05

4. Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry;Rheumatology and Therapy;2019-03-13

5. A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences;Advances in Therapy;2018-08-04